Logo image of BLMN

BLOOMIN' BRANDS INC (BLMN) Stock Fundamental Analysis

NASDAQ:BLMN - Nasdaq - US0942351083 - Common Stock - Currency: USD

9.255  +0.03 (+0.27%)

Fundamental Rating

3

Taking everything into account, BLMN scores 3 out of 10 in our fundamental rating. BLMN was compared to 132 industry peers in the Hotels, Restaurants & Leisure industry. While BLMN is still in line with the averages on profitability rating, there are concerns on its financial health. BLMN is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BLMN was profitable.
In the past year BLMN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BLMN reported negative net income in multiple years.
In the past 5 years BLMN always reported a positive cash flow from operatings.
BLMN Yearly Net Income VS EBIT VS OCF VS FCFBLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

BLMN has a Return On Assets of -0.06%. This is in the lower half of the industry: BLMN underperforms 62.88% of its industry peers.
BLMN's Return On Equity of -0.52% is in line compared to the rest of the industry. BLMN outperforms 53.03% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.46%, BLMN is in line with its industry, outperforming 51.52% of the companies in the same industry.
BLMN had an Average Return On Invested Capital over the past 3 years of 9.55%. This is below the industry average of 13.91%.
The 3 year average ROIC (9.55%) for BLMN is well above the current ROIC(5.46%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.06%
ROE -0.52%
ROIC 5.46%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
BLMN Yearly ROA, ROE, ROICBLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

BLMN's Operating Margin of 4.59% is on the low side compared to the rest of the industry. BLMN is outperformed by 63.64% of its industry peers.
BLMN's Operating Margin has improved in the last couple of years.
The Gross Margin of BLMN (71.00%) is better than 85.61% of its industry peers.
In the last couple of years the Gross Margin of BLMN has remained more or less at the same level.
Industry RankSector Rank
OM 4.59%
PM (TTM) N/A
GM 71%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
BLMN Yearly Profit, Operating, Gross MarginsBLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

2

2. Health

2.1 Basic Checks

BLMN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, BLMN has less shares outstanding
The number of shares outstanding for BLMN has been reduced compared to 5 years ago.
Compared to 1 year ago, BLMN has a worse debt to assets ratio.
BLMN Yearly Shares OutstandingBLMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BLMN Yearly Total Debt VS Total AssetsBLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BLMN has an Altman-Z score of 0.95. This is a bad value and indicates that BLMN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.95, BLMN is doing worse than 69.70% of the companies in the same industry.
The Debt to FCF ratio of BLMN is 35.06, which is on the high side as it means it would take BLMN, 35.06 years of fcf income to pay off all of its debts.
BLMN has a Debt to FCF ratio of 35.06. This is comparable to the rest of the industry: BLMN outperforms 42.42% of its industry peers.
A Debt/Equity ratio of 2.41 is on the high side and indicates that BLMN has dependencies on debt financing.
With a Debt to Equity ratio value of 2.41, BLMN perfoms like the industry average, outperforming 46.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF 35.06
Altman-Z 0.95
ROIC/WACC0.6
WACC9.15%
BLMN Yearly LT Debt VS Equity VS FCFBLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

BLMN has a Current Ratio of 0.41. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
BLMN has a worse Current ratio (0.41) than 81.82% of its industry peers.
A Quick Ratio of 0.33 indicates that BLMN may have some problems paying its short term obligations.
With a Quick ratio value of 0.33, BLMN is not doing good in the industry: 79.55% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.41
Quick Ratio 0.33
BLMN Yearly Current Assets VS Current LiabilitesBLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

0

3. Growth

3.1 Past

BLMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.74%.
BLMN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.30% yearly.
Looking at the last year, BLMN shows a very negative growth in Revenue. The Revenue has decreased by -17.68% in the last year.
The Revenue has been decreasing by -0.93% on average over the past years.
EPS 1Y (TTM)-35.74%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-15.71%
Revenue 1Y (TTM)-17.68%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-12.19%

3.2 Future

Based on estimates for the next years, BLMN will show a decrease in Earnings Per Share. The EPS will decrease by -7.57% on average per year.
Based on estimates for the next years, BLMN will show a decrease in Revenue. The Revenue will decrease by -2.85% on average per year.
EPS Next Y-31.45%
EPS Next 2Y-15.26%
EPS Next 3Y-7.57%
EPS Next 5YN/A
Revenue Next Year-11.44%
Revenue Next 2Y-5.17%
Revenue Next 3Y-2.85%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLMN Yearly Revenue VS EstimatesBLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BLMN Yearly EPS VS EstimatesBLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.48, the valuation of BLMN can be described as very cheap.
Based on the Price/Earnings ratio, BLMN is valued cheaper than 97.73% of the companies in the same industry.
BLMN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.48.
With a Price/Forward Earnings ratio of 7.16, the valuation of BLMN can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BLMN indicates a rather cheap valuation: BLMN is cheaper than 96.21% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of BLMN to the average of the S&P500 Index (36.52), we can say BLMN is valued rather cheaply.
Industry RankSector Rank
PE 5.48
Fwd PE 7.16
BLMN Price Earnings VS Forward Price EarningsBLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLMN indicates a rather cheap valuation: BLMN is cheaper than 95.45% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BLMN is valued a bit cheaper than the industry average as 64.39% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 30.08
EV/EBITDA 4.77
BLMN Per share dataBLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

BLMN's earnings are expected to decrease with -7.57% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.66
EPS Next 2Y-15.26%
EPS Next 3Y-7.57%

6

5. Dividend

5.1 Amount

BLMN has a Yearly Dividend Yield of 5.90%, which is a nice return.
BLMN's Dividend Yield is rather good when compared to the industry average which is at 3.47. BLMN pays more dividend than 95.45% of the companies in the same industry.
BLMN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 5.9%

5.2 History

On average, the dividend of BLMN grows each year by 19.12%, which is quite nice.
BLMN has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BLMN decreased in the last 3 years.
Dividend Growth(5Y)19.12%
Div Incr Years0
Div Non Decr Years2
BLMN Yearly Dividends per shareBLMN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of BLMN are negative and hence is the payout ratio. BLMN will probably not be able to sustain this dividend level.
DP-3723.47%
EPS Next 2Y-15.26%
EPS Next 3Y-7.57%
BLMN Yearly Income VS Free CF VS DividendBLMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BLOOMIN' BRANDS INC

NASDAQ:BLMN (7/18/2025, 10:55:01 AM)

9.255

+0.03 (+0.27%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)07-25 2025-07-25/bmo
Inst Owners103.97%
Inst Owner Change0%
Ins Owners1.65%
Ins Owner Change7.09%
Market Cap787.23M
Analysts54.44
Price Target8.97 (-3.08%)
Short Float %11.01%
Short Ratio3.37
Dividend
Industry RankSector Rank
Dividend Yield 5.9%
Yearly Dividend0.96
Dividend Growth(5Y)19.12%
DP-3723.47%
Div Incr Years0
Div Non Decr Years2
Ex-Date05-20 2025-05-20 (0.15)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.32%
Min EPS beat(2)2.96%
Max EPS beat(2)3.69%
EPS beat(4)3
Avg EPS beat(4)-1.61%
Min EPS beat(4)-13.76%
Max EPS beat(4)3.69%
EPS beat(8)6
Avg EPS beat(8)1.23%
EPS beat(12)10
Avg EPS beat(12)2.7%
EPS beat(16)13
Avg EPS beat(16)4.24%
Revenue beat(2)0
Avg Revenue beat(2)-0.49%
Min Revenue beat(2)-0.65%
Max Revenue beat(2)-0.32%
Revenue beat(4)0
Avg Revenue beat(4)-1.47%
Min Revenue beat(4)-2.62%
Max Revenue beat(4)-0.32%
Revenue beat(8)0
Avg Revenue beat(8)-1.81%
Revenue beat(12)2
Avg Revenue beat(12)-1.69%
Revenue beat(16)3
Avg Revenue beat(16)-1.56%
PT rev (1m)0%
PT rev (3m)-25.29%
EPS NQ rev (1m)3.24%
EPS NQ rev (3m)-26.39%
EPS NY rev (1m)-1.43%
EPS NY rev (3m)-7.19%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)-1.15%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.48%
Valuation
Industry RankSector Rank
PE 5.48
Fwd PE 7.16
P/S 0.21
P/FCF 30.08
P/OCF 3.46
P/B 2.07
P/tB N/A
EV/EBITDA 4.77
EPS(TTM)1.69
EY18.26%
EPS(NY)1.29
Fwd EY13.97%
FCF(TTM)0.31
FCFY3.32%
OCF(TTM)2.68
OCFY28.94%
SpS44.73
BVpS4.47
TBVpS-3.07
PEG (NY)N/A
PEG (5Y)1.66
Profitability
Industry RankSector Rank
ROA -0.06%
ROE -0.52%
ROCE 6.91%
ROIC 5.46%
ROICexc 5.58%
ROICexgc 7.54%
OM 4.59%
PM (TTM) N/A
GM 71%
FCFM 0.69%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
ROICexc(3y)9.93%
ROICexc(5y)N/A
ROICexgc(3y)14.52%
ROICexgc(5y)N/A
ROCE(3y)12.09%
ROCE(5y)N/A
ROICexcg growth 3Y-22.65%
ROICexcg growth 5Y1.95%
ROICexc growth 3Y-20.61%
ROICexc growth 5Y2.37%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
F-Score6
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF 35.06
Debt/EBITDA 2.66
Cap/Depr 118.44%
Cap/Sales 5.3%
Interest Coverage 2.88
Cash Conversion 66.07%
Profit Quality N/A
Current Ratio 0.41
Quick Ratio 0.33
Altman-Z 0.95
F-Score6
WACC9.15%
ROIC/WACC0.6
Cap/Depr(3y)141.63%
Cap/Depr(5y)109.75%
Cap/Sales(3y)6.11%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.74%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-15.71%
EPS Next Y-31.45%
EPS Next 2Y-15.26%
EPS Next 3Y-7.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.68%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-12.19%
Revenue Next Year-11.44%
Revenue Next 2Y-5.17%
Revenue Next 3Y-2.85%
Revenue Next 5YN/A
EBIT growth 1Y-46.89%
EBIT growth 3Y-18.98%
EBIT growth 5Y0.71%
EBIT Next Year32.37%
EBIT Next 3Y11.73%
EBIT Next 5YN/A
FCF growth 1Y-86.19%
FCF growth 3Y-70.21%
FCF growth 5Y-45.63%
OCF growth 1Y-47.45%
OCF growth 3Y-17.24%
OCF growth 5Y-6.4%